Research Topics
| B M ClarySummaryAffiliation: Duke University Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrenceB M Clary
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Ann Surg 233:250-8. 2001..To analyze the authors' experience with sentinel lymph node biopsy (SLNB) and the subsequent incidence and pattern of recurrence in patients with positive and negative nodes...
Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissectionB M Clary
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 8:328-37. 2001..To address this issue, we analyzed our experience with SLND and provided a comparison to patients treated with elective lymph node dissection (ELND)...
Hilar cholangiocarcinomaBryan Clary
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
J Gastrointest Surg 8:298-302. 2004..These summarizations are not meant as an exhaustive review and primarily reflect the opinions of the speakers based upon their experiences and interpretation of the existing literature...
Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparisonB M Clary
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 8:290-9. 2001..The pattern of distant spread follows the known patterns of hematogenous dissemination. Complete surgical resection is the cornerstone of treatment for primary GIST and LMS and in selected patients with local and distant recurrence...
Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasisPhilip Y Wai
MSRB, Room 437, 704 Research Drive, Duke University Medical Center, Durham, NC 27710, USA
Carcinogenesis 26:741-51. 2005..This study demonstrates that RNA interference stably reduces CT26 tumor expression of OPN and significantly attenuates CT26 colon cancer metastasis by diminishing tumor cell motility and invasiveness...
Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastasesMark Onaitis
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
Ann Surg 237:782-8; discussion 788-9. 2003..This fact, in light of the potential toxicity, would argue for a larger confirmatory trial of HAI in the adjuvant setting, incorporating recent advances in systemic therapy and careful attention to hepatotoxicity...
Treatment of isolated neuroendocrine liver metastasesBryan Clary
Duke University Medical Center, PO Box 3247, Durham, NC 27710, USA
J Gastrointest Surg 10:332-4. 2006
Selection of patients for resection of hepatic colorectal metastases: expert consensus statementChusilp Charnsangavej
Department of Radiology, M. D. Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 13:1261-8. 2006
Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablationSebastian T Schindera
Departments of Radiology, Duke University Medical Center, Box 3808, Erwin Road, Durham, NC 27710, USA
J Vasc Interv Radiol 17:1631-7. 2006..CONCLUSION: Percutaneous RF ablation offers a safe and effective treatment option for recurrent hepatic tumors after previous partial hepatectomy...
